Related Experiment Video

Updated: Mar 28, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K

Long noncoding RNAs in lung cancer: what we know in 2015

Y J Xu1, Y Du2, Y Fan3

  • 1Department of Chemotherapy, Zhejiang Cancer Hospital, 310022, Hangzhou, China.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|December 19, 2015
PubMed

Insights

Long noncoding RNAs (lncRNAs) are key players in lung cancer development. Understanding lncRNA functions can lead to better lung cancer biomarkers and treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer is a leading cause of cancer death globally and in China.
  • Low survival rates are linked to diagnostic challenges and metastasis.
  • Long noncoding RNAs (lncRNAs) are emerging as critical factors in cancer biology.

Purpose of the Study:

  • To review recent findings on the role of lncRNAs in lung cancer pathogenesis.
  • To explore the potential of lncRNAs as biomarkers and therapeutic targets for lung cancer.

Main Methods:

  • Literature review of recent studies on lncRNAs and lung cancer.
  • Analysis of lncRNA dysregulation in lung cancer onset and progression.

Main Results:

  • lncRNAs are frequently dysregulated in various cancers, including lung cancer.
  • lncRNAs play significant roles in the biological processes underlying lung cancer.
  • Current understanding of lncRNAs in lung cancer is still developing.

Conclusions:

  • lncRNAs are pivotal in lung cancer pathogenesis.
  • Further research into lncRNA activities is essential for developing novel biomarkers.
  • lncRNAs hold promise for improving treatment strategies for lung cancer patients.
Keywords:
Lung cancerNSCLClncRNA

More Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.9K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

514

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
14.0K